Edition:
United States

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

0.27USD
26 May 2017
Change (% chg)

$-0.00 (-0.41%)
Prev Close
$0.27
Open
$0.26
Day's High
$0.28
Day's Low
$0.26
Volume
270,220
Avg. Vol
778,483
52-wk High
$1.21
52-wk Low
$0.24

Latest Key Developments (Source: Significant Developments)

Amyris reports Q1 loss per share of $0.13
Monday, 15 May 2017 04:22pm EDT 

May 15 (Reuters) - Amyris Inc :Amyris reports 164 pct product revenue growth over prior year & continued strong outlook.Q1 loss per share $0.13.Q1 revenue rose 47 percent to $13 million.Q1 revenue view $32.3 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S."Expect to deliver around $60 million of product revenue for 2017"."Significant" progress in healthy sweeteners with expected commercial production in 2018 of low cost.Sees FY total revenue to be "better than" 2017 plan.Expects growing farnesene for vitamin E oil from around $6 million in 2016 to around $20 million in 2017.Expect to deliver around $60 million of product revenue for 2017, or more than double from 2016.  Full Article

DSM to make equity investment in Amyris
Monday, 8 May 2017 08:41am EDT 

May 8 (Reuters) - DSM ::ROYAL DSM TO MAKE EQUITY INVESTMENT IN AMYRIS <<>> WITH THE PURPOSE OF ESTABLISHING A LONG-TERM RELATIONSHIP.AGREED TO MAKE AN INITIAL EQUITY INVESTMENT IN AMYRIS OF US$25 MILLION, TRANSLATING INTO A SHAREHOLDING OF ABOUT 12 PCT.SUBJECT TO THE SATISFACTION OF CERTAIN CONDITIONS, DSM MAY INVEST AN ADDITIONAL US$25 MILLION IN AMYRIS.FIRST TRANCHE IS EXPECTED TO CLOSE ON MAY 11 2017, WITH SECOND TRANCHE, IF APPROVED BY DSM’S MANAGING BOARD, EXPECTED TO CLOSE WITHIN 90 DAYS OF CLOSING OF FIRST TRANCHE.  Full Article

Amyris says entered into securities purchase agreement with certain investors
Monday, 8 May 2017 08:34am EDT 

May 8 (Reuters) - Amyris Inc :Amyris inc - on may 8, 2017, amyris, inc. Entered into a securities purchase agreement with certain investors - sec filing.Amyris inc expects net proceeds from sale of securities to be about $44.5 million.Amyris inc - intends to use about $9.5 million of net proceeds from offering for redemption of convertible notes issued by co in dec 2016 and april 2017.Amyris inc says to sell 22,140 shares of co's s series a 17.38% convertible preferred stock, about 65,203 shares of co's series b 17.38% convertible preferred stock.  Full Article

Amyris announces agreements for up to $95 mln in equity financing
Monday, 8 May 2017 08:30am EDT 

May 8 (Reuters) - Amyris Inc :Amyris announces agreements for up to $95 million in equity financing and in-process initiative to significantly reduce debt.Equity financing commitment includes participation by Koninklijke DSM N.V., DSM agreed to initial equity investment in Co of $25 million.Subject to satisfaction of certain conditions, DSM may invest an additional $25 million in Amyris.Is in process of reducing its debt by about $75 million, about $40 million of such amount is being converted pursuant to terms of equity financing.  Full Article

Amyris makes develomental progress in its healthy sweetener product technology
Monday, 1 May 2017 08:00am EDT 

May 1 (Reuters) - Amyris Inc -:Amyris Inc - made significant progress in development of its healthy sweetener product technology and expects industrial production to occur in 2018.Expects sweetener product opportunity in partnership with its partner to deliver over $100 million in annual revenue by 2020.  Full Article

Amyris agrees to China manufacturing with Blue California
Tuesday, 18 Apr 2017 07:45am EDT 

April 18 (Reuters) - Amyris Inc :Amyris agrees to exclusive China manufacturing with Blue California enabling continued record product revenue growth into Asian markets.Amyris - agreement whereby affiliates will provide access to fermentation manufacturing in China, capital to produce no compromise ingredients for co.Amyris Inc - company expects to generate $50 million or more in revenue over next 12-18 months from its sales into China.  Full Article

Amyris updates on its liquidity needs
Monday, 17 Apr 2017 05:55pm EDT 

April 17 (Reuters) - Amyris Inc :Amyris Inc <<>> says it will likely need additional financing as early as the second quarter of 2017 to support its liquidity needs - SEC filing.Amyris Inc <<>> - If unable to raise additional financing, its ability to continue as a going concern would be jeopardized and may be unable to meet its obligations under existing debt facilities.  Full Article

Amyris says on Feb. 27, Co and Total Amyris Biosolutions B.V. entered into first amendment to research and development note
Friday, 3 Mar 2017 04:21pm EST 

Amyris Inc : Amyris inc- on february 27, 2017, company and total amyris biosolutions b.v. Entered into a first amendment to research and development note - sec filing .Amyris inc - pursuant to first amendment, parties agreed to extend maturity date of research and development note from march 1, 2017 to may 15, 2017.  Full Article

Amyris Q4 loss per share $0.14
Thursday, 2 Mar 2017 04:00pm EST 

Amyris Inc : Amyris more than doubles revenues over 2015 and provides strong growth outlook . Q4 revenue $32.2 million versus i/b/e/s view $38.7 million . Q4 loss per share $0.14 . Says sees more than doubling product revenues in 2017 while maintaining its strong performance in collaborations .Says 2017 growth outlook based on co's strong competitive position, currently contracted business and pipeline.  Full Article

Temasek Holdings reports 22.1 pct stake in Amyris as of Feb. 23
Monday, 27 Feb 2017 07:05am EST 

Amyris Inc : Temasek holdings (private) ltd reports 22.1 percent stake in amyris inc as of feb 23 - sec filing .Temasek holdings (private) ltd had reported a stake of 23.2 percent in amyris inc as of jan 6.  Full Article

More From Around the Web

BRIEF-Amyris reports Q1 loss per share of $0.13

* Amyris reports 164 pct product revenue growth over prior year & continued strong outlook